Document Detail


The safety and efficacy of clozapine in severe treatment-resistant schizophrenic patients in the UK. Clozapine Study Group.
MedLine Citation:
PMID:  8075904     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In order to assess the safety and some efficacy aspects of clozapine under UK conditions, 54 in-patients with severe treatment-resistant schizophrenic disorders were evaluated using several scales before and during treatment. Of the 54 evaluated, 26 completed the 26-week study. Of these patients, 20 showed improvement in psychopathology, often to a marked degree, involving both positive and negative symptoms. Some oral-facial extrapyramidal side-effects decreased as well. Two patients developed neutropenia, but recovered on discontinuation of clozapine. The most frequent adverse event was hypersalivation, and five patients suffered from seizures. It is concluded that clozapine is worth considering for the treatment of severe treatment-resistant patients in the UK.
Authors:
-
Related Documents :
3057814 - Group therapy with schizophrenic patients in outpatient departments.
10823414 - Selective impairments in the stress response in schizophrenic patients.
2576964 - Course of psychosis in algeria and in france: about 342 cases observed from 1975 to 1985.
3628624 - The positive and negative symptoms of schizophrenia reflect impairments in the percepti...
24389294 - Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy su...
1515094 - Plasma lactoferrin content in neutropenic patients: effects of treatment with recombina...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study    
Journal Detail:
Title:  The British journal of psychiatry : the journal of mental science     Volume:  163     ISSN:  0007-1250     ISO Abbreviation:  Br J Psychiatry     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1994-10-04     Completed Date:  1994-10-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0342367     Medline TA:  Br J Psychiatry     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  150-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Chronic Disease
Clozapine / adverse effects,  pharmacology,  therapeutic use*
Drug Resistance
Dyskinesia, Drug-Induced
Female
Great Britain
Humans
Male
Middle Aged
Neutropenia
Schizophrenia / drug therapy*
Schizophrenic Psychology*
Sialorrhea
Treatment Outcome
Chemical
Reg. No./Substance:
5786-21-0/Clozapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Psychiatric symptoms in cannabis users.
Next Document:  A single photon emission computerised tomography study of regional brain function in elderly patient...